Your browser doesn't support javascript.
loading
Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.
Jimenez Jimenez, Antonio M; De Lima, Marcos; Komanduri, Krishna V; Wang, Trent P; Zhang, Mei-Jie; Chen, Karen; Abdel-Azim, Hisham; Abid, Muhammad Bilal; Aljurf, Mahmoud; Alkhateeb, Hassan; Assal, Amer; Bacher, Ulrike; Baron, Frédéric; Battiwalla, Minoo; Beitinjaneh, Amer; Bejanyan, Nelli; Bhatt, Vijaya Raj; Byrne, Michael; Cahn, Jean-Yves; Cairo, Mitchell; Castillo, Paul; Copelan, Edward; DeFilipp, Zachariah; Perez, Miguel Angel Diaz; Elsawy, Mahmoud; Gale, Robert Peter; George, Biju; Grunwald, Michael R; Hildebrandt, Gerhard C; Hogan, William J; Kanakry, Christopher G; Kansagra, Ankit; Kharfan-Dabaja, Mohamed A; Khera, Nandita; Krem, Maxwell M; Lazaryan, Aleksandr; Maakaron, Joseph; Martino, Rodrigo; McGuirk, Joseph; Michelis, Fotios V; Milone, Giuseppe; Mishra, Asmita; Murthy, Hemant S; Mussetti, Alberto; Nathan, Sunita; Nishihori, Taiga; Olsson, Richard F; Palmisiano, Neil; Patel, Sagar; Saad, Ayman.
Afiliação
  • Jimenez Jimenez AM; Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA. amjimenez@med.miami.edu.
  • De Lima M; Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
  • Komanduri KV; Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Wang TP; Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Zhang MJ; (CIBMTR)® Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Chen K; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Abdel-Azim H; (CIBMTR)® Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Abid MB; Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
  • Aljurf M; Divisions of Hematology/Oncology & Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Alkhateeb H; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • Assal A; Mayo Clinic Rochester, Rochester, MN, USA.
  • Bacher U; Columbia University Irving Medical Center, Department of Medicine, Bone Marrow Transplant and Cell Therapy Program, New York, NY, USA.
  • Baron F; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Battiwalla M; CHU and University of Liege, Liege, Belgium.
  • Beitinjaneh A; Sarah Cannon Blood Cancer Network, Nashville, TN, USA.
  • Bejanyan N; Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Bhatt VR; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL, USA.
  • Byrne M; The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
  • Cahn JY; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Cairo M; Department of Hematology, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France.
  • Castillo P; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, NY, USA.
  • Copelan E; UF Health Shands Children's Hospital, Gainesville, FL, USA.
  • DeFilipp Z; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Perez MAD; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA, USA.
  • Elsawy M; Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain.
  • Gale RP; Division of Hematology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.
  • George B; Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • Grunwald MR; Christian Medical College, Vellore, India.
  • Hildebrandt GC; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Hogan WJ; Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
  • Kanakry CG; Division of Hematology/BMT, Mayo Clinic, Rochester, MN, USA.
  • Kansagra A; Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Kharfan-Dabaja MA; UT Southwestern Medical Center, Blood and Marrow Transplant Program, Dallas, TX, USA.
  • Khera N; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.
  • Krem MM; Department of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Lazaryan A; Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, USA.
  • Maakaron J; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL, USA.
  • Martino R; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • McGuirk J; Divison of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Michelis FV; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Minneapolis, MN, USA.
  • Milone G; Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Mishra A; Azienda Ospedaliera Universitaria Policlinico-San Marco, Catania, Italy.
  • Murthy HS; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL, USA.
  • Mussetti A; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.
  • Nathan S; Hematology Department, Institut Catalá d' Oncologia-Hospitalet, Barcelona, Spain.
  • Nishihori T; IDIBELL-Institut Catalá d' Oncologia, l'Hospitalet de Llobregat, El Prat de Llobregat, Spain.
  • Olsson RF; Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL, USA.
  • Palmisiano N; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL, USA.
  • Patel S; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Saad A; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
Bone Marrow Transplant ; 57(5): 852, 2022 May.
Article em En | MEDLINE | ID: mdl-35297406
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos